Skip to Content

TMZ 20 (Temozolomide 20 mg)

Pill with imprint TMZ 20 is White & Yellow, Capsule-shape and has been identified as Temozolomide 20 mg. It is supplied by Accord Healthcare Inc..

Temozolomide is used in the treatment of glioblastoma multiforme; anaplastic astrocytoma; anaplastic oligodendroglioma; melanoma, metastatic; melanoma and belongs to the drug class alkylating agents. There is positive evidence of human fetal risk during pregnancy. Temozolomide 20 mg is not a controlled substance under the Controlled Substance Act (CSA).

Images for TMZ 20

Temozolomide

Imprint:
TMZ 20
Strength:
20 mg
Color:
White & Yellow
Shape:
Capsule-shape
Availability:
Prescription only
Drug Class:
Alkylating agents
Pregnancy Category:
D - Positive evidence of risk
CSA Schedule:
Not a controlled drug
Labeler / Supplier:
Accord Healthcare Inc.
National Drug Code (NDC):
16729-0049

Get help with Imprint Code FAQs.

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2017 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide